Drug safety notice: Pabrinex

December 11, 2023

There is currently a shortage of Pabrinex intravenous high potency, concentrate for solution for infusion.

We are expecting new stock of the product at some point this week.

We ask clinical colleagues ensure that Pabrinex is used in line with Trust guidelines and the BNF. Use Pabrinex judiciously to conserve stock for patients with no other treatment options.

Please see Safety Notice Pabrinex for further details.

For more information please contact the pharmacy department on ext. 5263/3783.